While Hims & Hers Health Inc has underperformed by -5.13%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HIMS rose by 44.62%, with highs and lows ranging from $72.98 to $23.97, whereas the simple moving average fell by -23.64% in the last 200 days.
On December 09, 2025, Barclays started tracking Hims & Hers Health Inc (NYSE: HIMS) recommending Overweight. A report published by KeyBanc Capital Markets on October 21, 2025, Initiated its previous ‘Sector Weight’ rating for HIMS. Needham Reiterated the rating as Buy on June 04, 2025, but set its price target from $61 to $65. TD Cowen April 29, 2025d its ‘Buy’ rating to ‘Hold’ for HIMS, as published in its report on April 29, 2025. Morgan Stanley’s report from February 18, 2025 suggests a price prediction of $60 for HIMS shares, giving the stock a ‘Equal-Weight’ rating. Citigroup also rated the stock as ‘Sell’.
Analysis of Hims & Hers Health Inc (HIMS)
Further, the quarter-over-quarter increase in sales is 49.16%, showing a positive trend in the upcoming months.
One of the most important indicators of Hims & Hers Health Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 26.21% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.64, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and HIMS is recording 25.04M average volume. On a monthly basis, the volatility of the stock is set at 5.68%, whereas on a weekly basis, it is put at 5.48%, with a loss of -7.68% over the past seven days. Furthermore, long-term investors anticipate a median target price of $46.91, showing growth from the present price of $34.97, which can serve as yet another indication of whether HIMS is worth investing in or should be passed over.
How Do You Analyze Hims & Hers Health Inc Shares?
The Drug Manufacturers – Specialty & Generic market is dominated by Hims & Hers Health Inc (HIMS) based in the USA. When comparing Hims & Hers Health Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 64.65, there is a growth in quarterly earnings of -80.29%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 10.09%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 89.50% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
